I'm LongbridgeAI, I can summarize articles.During Monday's pre-market session, several healthcare stocks experienced significant volatility. Disc Medicine (IRON) surged 50.4% to $85.51, while DataMEDS AI (MEDS) rose 19.77%. Other gainers included Virax Biolabs (VRAX), Alaunos Therapeutics (TCRT), Akari Therapeutics (AKTX), and Rapport Therapeutics (RAPP). Conversely, EyePoint Pharmaceuticals (EYPT) plummeted 80.0% to $0.60. Additional decliners were CDT Equity (CDT), Actuate Therapeutics (ACTU), Sera Prognostics (SERA), Matinas BioPharma (MTNB), and Estrella Immunopharma (ESLA).
Gainers
- Disc Medicine (NASDAQ:IRON) stock moved upwards by 50.4% to $85.51 during Monday's pre-market session. The company's market cap stands at $2.1 billion.
- DataMEDS AI (NASDAQ:MEDS) shares moved upwards by 19.77% to $3.15. The market value of their outstanding shares is at $9.1 million.
- Virax Biolabs Group (NASDAQ:VRAX) stock moved upwards by 17.24% to $1.7. The company's market cap stands at $1.2 million.
- Alaunos Therapeutics (NASDAQ:TCRT) stock rose 17.11% to $3.08. The company's market cap stands at $5.5 million.
- Akari Therapeutics (NASDAQ:AKTX) stock rose 13.01% to $9.24. The market value of their outstanding shares is at $20.2 million.
- Rapport Therapeutics (NASDAQ:RAPP) shares rose 12.44% to $31.0. The company's market cap stands at $1.4 billion.
Losers
- EyePoint (NASDAQ:EYPT) shares decreased by 80.0% to $0.6 during Monday's pre-market session. The company's market cap stands at $270.7 million.
- CDT Equity (NASDAQ:CDT) stock declined by 12.81% to $0.2.
- Actuate Therapeutics (NASDAQ:ACTU) shares decreased by 12.32% to $0.53. The company's market cap stands at $12.0 million.
- Sera Prognostics (NASDAQ:SERA) stock fell 10.2% to $1.85. The company's market cap stands at $80.0 million.
- Matinas BioPharma Hldgs (AMEX:MTNB) stock decreased by 9.29% to $2.15. The market value of their outstanding shares is at $35.5 million.
- Estrella Immunopharma (NASDAQ:ESLA) stock decreased by 8.45% to $0.39. The market value of their outstanding shares is at $23.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock894characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.